Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 278,349
▼ 65% vs 2024
Profit
Caution€ -10,933
▼ 124% vs 2024
Debts
Normal€ 7 million
▼ 1% vs 2024
BLUESTONE from Elsene, company number BE0473173918, closed financial year 2025 with a result of € -10,933 after tax. For that financial year BLUESTONE recorded a gross margin of € 278,349 and equity of € 2.5 million. Compared with financial year 2024, the result moved from € 45,450 to € -10,933. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
What happened at BLUESTONE?
What happened at BLUESTONE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 10,933 (▼ 124% vs 2024). Source: NBB ↗
- PAUL RANSART became a director. NBB
- New establishment in Elsene. KBO
- Start of the company according to the CBE. KBO
In short
From € 86,861 profit in 2021 to € 10,933 loss in 2025.
Paid € 147,228 in corporate taxes since 2021.
Best year ever: 2023, with € 180,941 profit.
Paid out € 25,000 in dividends to the owners in total.
A new publication or filing at BLUESTONE? We notify you, reason included.
Follow BLUESTONENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind BLUESTONE is PAUL RANSART. It owns 99.5% of PARGEFI, 80% of PHARMANEXT, 51.4% of PALATINE, 50% of TAMIPHAR, 50% of LENANS and 31.3% of CITYPHAR itself.
Directors
According to the 2025 annual accounts
PAUL RANSART
Manager
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE +20 more
since 2016
Establishments
Establishment units
Physical locations of this company
Solbossquare 30
1050 Elsene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
PHARMANEXT same network
€ 485,409 gross margin · 2025
Association des copropriétaires de l'immeuble sis à Ixelles, square du Solbosch 30
A.C.P. SOLBOSCH 30 ACP
Société de Participations et de Gestion Financières et Immobilières same network
€ 8,605 revenue · 2025
Elisamed SNC - Cabinet de médecine générale et d'expertise médicale - Docteurs JM DUMONT et ML TEICHMANN
Details
- Company number
- 0473.173.918
- VAT number
- BE 0473.173.918
- Registered office
- Solbossquare 30, 1050 Elsene
- Names & denominations
- BLUESTONE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 October 2000
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Activiteiten van hoofdkantoren